Authors:
Robinson, RP
Laird, ER
Donahue, KM
Lopresti-Morrow, LL
Mitchell, PG
Reese, MR
Reeves, LM
Rouch, AI
Stam, EJ
Yocum, SA
Citation: Rp. Robinson et al., Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors, BIOORG MED, 11(9), 2001, pp. 1211-1213
Authors:
Robinson, RP
Laird, ER
Blake, JF
Bordner, J
Donahue, KM
Lopresti-Morrow, LL
Mitchell, PG
Reese, MR
Reeves, LM
Stam, EJ
Yocum, SA
Citation: Rp. Robinson et al., Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold, J MED CHEM, 43(12), 2000, pp. 2293-2296
Authors:
Reiter, LA
Rizzi, JP
Pandit, J
Lasut, MJ
McGahee, SM
Parikh, VD
Blake, JF
Danley, DE
Laird, ER
Lopez-Anaya, A
Lopresti-Morrow, LL
Mansour, MN
Martinelli, GJ
Mitchell, PG
Owens, BS
Pauly, TA
Reeves, LM
Schulte, GK
Yocum, SA
Citation: La. Reiter et al., Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S-2 pocket, BIOORG MED, 9(2), 1999, pp. 127-132